City
Epaper

Beta-blockers well-tolerated drug, does not commonly lower potassium levels: Experts

By IANS | Updated: January 10, 2025 17:35 IST

New Delhi, Jan 10 Beta blockers are not commonly known to lower potassium levels, and are a well-tolerated ...

Open in App

New Delhi, Jan 10 Beta blockers are not commonly known to lower potassium levels, and are a well-tolerated drug, said experts on Friday, expressing concerns on government body’s alert on these commonly used medicines for blood pressure and heart.

Beta-blockers are commonly prescribed drugs for conditions like irregular heartbeat and hypertension. It works by blocking the action of hormones like adrenaline on nerve cells, causing blood vessels to relax and dilate (widen), and also slows down the heart.

Earlier this week, the Indian Pharmacopoeia Commission (IPC), an autonomous body under the Union Health Ministry, issued a warning that beta-blockers, commonly prescribed drugs for conditions like irregular heartbeat and hypertension, can cause potentially serious risk of low potassium levels, known as hypokalaemia.

Low potassium symptoms can lead to symptoms, including muscle weakness, fatigue, heart palpitations, and high blood pressure, among others.

“Beta blockers are not commonly known to cause hypokalaemia,” Dr. Rajeev Jayadevan, Chairman of the Kerala State IMA Research Cell, told IANS, noting that people “taking only a beta-blocker is extremely unlikely to develop this problem”.

Jayadevan explained that “low potassium levels can be caused only in people who use diuretics such as hydrochlorothiazide and frusemide”. Diuretics are medicines that help reduce fluid buildup in the body.

“Diuretics are often taken together with beta-blockers by people who have high blood pressure. Hypokalaemia or low potassium level is known to cause muscle cramps, weakness, and dangerous rhythm abnormalities of the heart. Thus, someone who is taking only a beta blocker is extremely unlikely to develop this problem,” Jayadevan told IANS.

In its latest alert, the IPC advised healthcare professionals, patients/consumers "to closely monitor the possibility of the adverse drug reaction with the use of the suspected drugs". Beta-blockers mentioned in the drug safety alert include Metoprolol, Propranolol, and Atenolol.

Cardiologist Dr Ashwani Mehta, from a city-based hospital, called the move unnecessary which has caused panic among patients.

“We have been using beta blockers in a big way in our country for the last about 25 to 30 years. Rarely has any of our patients developed hypokalemia, until and unless there is any kind of serious comorbidities associated which per se led to hypokalemia”, Mehta said.

“I do not think that beta blockers can cause significant hyperkalemia. They are one of the very well-tolerated drugs. This alert has created a panic in the general public, which is really not required,” Mehta said.

The Cardiologist assured people to “not be worried about the various side effects”.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalTrump repeats claim of 'solving' India-Pakistan war; says "going to have success" on Ukraine issue

Cricket"Pressure Mounts": Nasser Hussain on India's must-win game against England

FootballIndia come from behind to seal maiden AFC U17 Women's Asian Cup qualification

CricketShreyas Iyer on verge of completing 3000 ODI and 5000 international runs

International"They are pulling back": Trump repeats claim of India "not be buying" Russian oil

Technology Realted Stories

TechnologyWe're actually living in the first Indian decade of that Indian century: Nick Booker

TechnologyIndia has become leader in telecom services, product: Jyotiraditya M. Scindia

TechnologyFrom ‘Fragile 5’ to top 5, India doubles down on reforms across sectors: PM Modi

TechnologyKaynes Semicon dispatches India's first commercial multi-chip module to US firm

TechnologyChina’s green energy drive poses grave danger to Tibet’s fragile ecology